Last 1,380 INR
Change Today -32.05 / -2.27%
Volume 19.9K
PFIZ On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

pfizer limited (PFIZ) Snapshot

Open
1,425
Previous Close
1,413
Day High
1,425
Day Low
1,375
52 Week High
12/2/13 - 1,779
52 Week Low
07/29/13 - 963.89
Market Cap
41.2B
Average Volume 10 Days
14.1K
EPS TTM
45.95
Shares Outstanding
29.8M
EX-Date
12/5/13
P/E TM
30.0x
Dividend
360.00
Dividend Yield
28.44%
Current Stock Chart for PFIZER LIMITED (PFIZ)

Related News

No related news articles were found.

pfizer limited (PFIZ) Related Businessweek News

No Related Businessweek News Found

pfizer limited (PFIZ) Details

Pfizer Limited provides various pharmaceutical products in India and internationally. The company offers products in the areas of anti-infectives, anti-fungal, anti-TB, neuropathic pain, antifibrinolytic, dermatology, dyslipidemia, gastrointestinal, GI–hyperacidity, GERD, gynecology, immune enhancer, inflammation, multi-vitamin, neurology, nutraceutical, ophthalmology, otology, respiratory, trichology, urinary alkanizer, urology, and cardiovascular, including hypertension, acidity, smoking cessation, and angina. Its Pharmaceuticals segment manufactures and trades in formulations, as well as provides marketing services. The company’s Services segment is involved in clinical development operations, which primarily include conducting clinical trials, new product development, and undertaking data management for drug development. Pfizer Limited was incorporated in 1950 and is headquartered in Mumbai, India.

Founded in 1950

pfizer limited (PFIZ) Top Compensated Officers

Managing Director, Additional Director and Me...
Total Annual Compensation: 17.6M
Executive Director of Technical Operations, W...
Total Annual Compensation: 8.0M
Compensation as of Fiscal Year 2013.

pfizer limited (PFIZ) Key Developments

Pfizer Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Pfizer Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 2,398.5 million against INR 2,375.3 million for the same period of last year. Profit from operations before other income, finance costs and exceptional items was INR 599.9 million against INR 427 million for the same period of last year. Profit from ordinary activities before tax was INR 699.5 million against INR 731.1 million for the same period of last year. Net profit from ordinary activities after tax was INR 461.5 million or INR 15.47 per basic and diluted share against INR 476.3 million or INR 15.96 per basic and diluted share for the same period of last year.

Pfizer Limited to Report Q1, 2015 Results on Jul 24, 2014

Pfizer Limited announced that they will report Q1, 2015 results on Jul 24, 2014

Pfizer Limited, Board Meeting, Jul 24, 2014

Pfizer Limited, Board Meeting, Jul 24, 2014. Agenda: To consider and take on record the unaudited financial results of the company for the first quarter ended June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFIZ:IN 1,380.45 INR -32.05

PFIZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 2,088 INR -20.55
Array BioPharma Inc $4.18 USD -0.10
Merit Medical Systems Inc $14.82 USD -0.22
Sagent Pharmaceuticals Inc $26.16 USD -0.50
Spectrum Pharmaceuticals Inc $7.05 USD -0.05
View Industry Companies
 

Industry Analysis

PFIZ

Industry Average

Valuation PFIZ Industry Range
Price/Earnings 18.6x
Price/Sales 3.7x
Price/Book 6.2x
Price/Cash Flow 18.0x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER LIMITED, please visit www.pfizerindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.